Nick Bansback
ORCID: 0000-0002-1510-3462Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Jing Li, Nick Bansback, Chien‐Wen Tseng, Steve Shiboski, Gabriela Schmajuk +2 more
Papers
Driven by 2 papers — median percentile 61. Top paper: “Patterns of Infliximab Biosimilar Uptake for Medicare, Medicaid, and Private Insurance from 2016 to 2022”.
Jing Li, Nick Bansback, Chien‐Wen Tseng, Steve Shiboski, Gabriela Schmajuk +2 more
Jeffrey R. Curtis, Jie Huang, Zhe He, Michael Evans, Tracy Johansson +4 more